Since 2016, MAT has run close to 700 projects across 45 countries on the RPR platform. Learn about how we have helped our clients expand and deepen their insights - gathering feedback from our global payer network to inform pivotal product development decisions across a range of treatment areas and phases.
RPR in action
Robust Reviews explore a variety of situations where global pharmaceutical and device manufacturers have leveraged RPR instead of traditional payer research methods. These case studies span treatment areas, development phases, and markets. Interested in learning more? Contact us and a member of our Commercial team will be in touch.
Comprehensive reports spanning multiple payer research initiatives give broad insight into trends and themes across the market access landscape
Seen at ISPOR
Approved posters from previous ISPOR conferences